The feasibility of using a configurable, source-grounded extraction workflow to convert fragmented oncology documentation into reusable structured data is supported.
Abstract
Clinically relevant oncology information is distributed across heterogeneous, longitudinal documentation, creating substantial abstraction burden and requiring accurate attribution across specimens, tumors, biomarkers, and time points, while manual cancer-registry abstraction can require 27.2 minutes per case, highlighting the need for scalable methods that preserve clinical context while converting documentation into structured data. We evaluate an oncology information-extraction workflow in which OncoLens supplies multi-source, oncology-aware document selection, aggregation, and normalization from integrated EHRs, while the NimbleMind Multi-Agent System (nMAS) is a configurable oncology information-extraction workflow that extracts clinically relevant structured fields from fragmented oncology documentation. The extraction task uses a clinician-informed schema of 328 attributes spanning report metadata, diagnosis, staging, and cancer-type-specific information. nMAS separates clinician-defined field specifications from model execution and combines complexity-aware extraction, report-level consolidation, and source-grounded validation. The retrospective evaluation included 230 de-identified oncology documents from 40 patients and 418 clinician-reviewed document-field pairs containing 1,126 non-empty reference values. Evaluation focused on fields identified by clinicians as present in the source documents rather than exhaustively annotating all 328 schema fields. nMAS achieved a rank-weighted value-level precision of 82.6%, recall of 87.5%, and F1 of 85.0%, compared with an F1 of 66.4% for an independently implemented UMA-style MiniMax M2.5 comparator. These findings support the feasibility of using a configurable, source-grounded extraction workflow to convert fragmented oncology documentation into reusable structured data.
This Viewpoint defines an AI agent as a feedback-driven system that maintains task state, selects among governed tools, observes results, and revises its plan under explicit safety constraints, and separates agents from multimodal foundation models, retrieval-augmented generation, and fixed workflow automation.
Liu-Yang Yang, Liyu Shan, Xiang-Mei Yao et al.· JMIR Cancer· 0 citations
Three open-source optical character recognition approaches are evaluated and compared to determine which best enables automated extraction of Oncotype DX recurrence scores and improves the timeliness and quality of real-world oncology data.
Qian-Yun Luo, Rui Zhang, Nikitha Vobugari et al.· Cancer Causes and Control· 0 citations
The GENIE Data Model (GDM), a comprehensive, open-source, oncology data model for scalable, consistent, and interoperable data collection across solid tumors designed to effectively capture the patient's journey with cancer, is developed.
J. Hoppe, Jocelyn Lee, T. Akinyemiju et al.· Cancer Research Communicatio...· 0 citations
OncoRAG enables accurate clinical phenotyping from multilingual oncology notes using a locally deployable mid-size model, without model weight fine-tuning or external data sharing.
P. Salome, M. Knoll, David Walz et al.· npj Digital Medicine· 0 citations
The rapid expansion of the oncology literature has outpaced manual curation of clinically relevant gene-cancer-drug associations and oncogenic driver evidence. Existing automated approaches often lack transparency or are difficult to scale across heterogeneous data sources. To address this gap, we developed megaMine, a...
Muhammad Junaid, K. Prazanowska, Ha-Eun Jeong et al.· bioRxiv· 0 citations
Recent advances and emerging translational evidence for clinically oriented MML in glioblastoma is summarized, with particular emphasis on MRI-centered systems that integrate imaging with pathology, selected molecular measurements, and longitudinal clinical context.
Amin Zadeh-Shirazi, Bryan W. Day, Hui K. Gan et al.· Frontiers in Oncology· 0 citations